aminosalicylic acid has been researched along with Adverse Drug Event in 9 studies
Aminosalicylic Acid: An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.
4-aminosalicylic acid : An aminobenzoic acid that is salicylic acid substituted by an amino group at position 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These drugs are associated with numerous adverse events that can cause severe morbidity, such as deafness, and in some instances can lead to death." | 2.66 | Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. ( Ahmad, N; Baghaei, P; Barkane, L; Benedetti, A; Brode, SK; Brust, JCM; Campbell, JR; Chang, VWL; Falzon, D; Guglielmetti, L; Isaakidis, P; Kempker, RR; Kipiani, M; Kuksa, L; Lan, Z; Lange, C; Laniado-Laborín, R; Menzies, D; Nahid, P; Rodrigues, D; Singla, R; Udwadia, ZF, 2020) |
| "Ethionamide and PAS were the most frequently reported drugs that associated with the occurrence of hypothyroidism." | 2.61 | Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis. ( Holakouie-Naieni, K; Lejisa, T; Mansournia, MA; Mola, M; Tesfaye, E; Tola, HH; Yaseri, M, 2019) |
| " We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Dhaneshwar, SS | 1 |
| Chail, M | 1 |
| Patil, M | 1 |
| Naqvi, S | 1 |
| Vadnerkar, G | 1 |
| Chen, M | 1 |
| Vijay, V | 1 |
| Shi, Q | 2 |
| Liu, Z | 2 |
| Fang, H | 2 |
| Tong, W | 2 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Sakatis, MZ | 1 |
| Reese, MJ | 1 |
| Harrell, AW | 1 |
| Taylor, MA | 1 |
| Baines, IA | 1 |
| Chen, L | 1 |
| Bloomer, JC | 1 |
| Yang, EY | 1 |
| Ellens, HM | 1 |
| Ambroso, JL | 1 |
| Lovatt, CA | 1 |
| Ayrton, AD | 1 |
| Clarke, SE | 1 |
| Lan, Z | 1 |
| Ahmad, N | 1 |
| Baghaei, P | 1 |
| Barkane, L | 1 |
| Benedetti, A | 1 |
| Brode, SK | 1 |
| Brust, JCM | 1 |
| Campbell, JR | 1 |
| Chang, VWL | 1 |
| Falzon, D | 1 |
| Guglielmetti, L | 1 |
| Isaakidis, P | 1 |
| Kempker, RR | 1 |
| Kipiani, M | 1 |
| Kuksa, L | 1 |
| Lange, C | 1 |
| Laniado-Laborín, R | 1 |
| Nahid, P | 1 |
| Rodrigues, D | 1 |
| Singla, R | 1 |
| Udwadia, ZF | 1 |
| Menzies, D | 1 |
| Tola, HH | 1 |
| Holakouie-Naieni, K | 1 |
| Lejisa, T | 1 |
| Mansournia, MA | 1 |
| Yaseri, M | 1 |
| Tesfaye, E | 1 |
| Mola, M | 1 |
| STERNE, TL | 1 |
| EVANS, DA | 1 |
| JANCSIN, J | 1 |
2 reviews available for aminosalicylic acid and Adverse Drug Event
| Article | Year |
|---|---|
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Canada; Clofazimine; Diarylquinolines; Drug-Relat | 2020 |
Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
Topics: Aminosalicylic Acid; Antitubercular Agents; Cross-Sectional Studies; Drug-Related Side Effects and A | 2019 |
7 other studies available for aminosalicylic acid and Adverse Drug Event
| Article | Year |
|---|---|
Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.
Topics: Aminosalicylic Acids; Animals; Colitis; Colon; Drug Delivery Systems; Drug Stability; Drug-Related S | 2009 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
Exchange transfusion for aspirin poisoning.
Topics: Aminosalicylic Acid; Aspirin; Blood Transfusion; Drug-Related Side Effects and Adverse Reactions; Ex | 1959 |
INDIVIDUAL VARIATIONS OF DRUG METABOLISM AS A FACTOR IN DRUG TOXICITY.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug-Related Side Effects and Adverse Reactions; Enzyme I | 1965 |
[Drug intoxication in combined PAS-streptomycin therapy].
Topics: Aminosalicylic Acid; Drug-Related Side Effects and Adverse Reactions; Psychotherapy, Multiple; Strep | 1952 |